Publications Office of the EU
Czechia-Prague: Antineoplastic agents - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Czechia-Prague: Antineoplastic agents

Overview
  • Published
    27/09/2021
  • Deadline
    27/10/2021
  • Awarded
    13/12/2021
  • Today
    20/07/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Fakultní nemocnice v Motole
Place of performance
NUTS code: CZ010 Hlavní město Praha
Location of buyer
NUTS code: CZ010 Hlavní město Praha
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
14,766,780.00 CZK
Total final contract value (excluding VAT)
14,765,323.50 CZK
Procedure details
Tender reference number
140/21
Description

Dodávky léčivého přípravku s účinnou látkou Lenvatinib.

Submission Method
Electronic via:
www.egordion.cz/nabidkaGORDION/profilFnm
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Check linked documents for details
Place of performance
CZ010 Hlavní město Praha
CPV code

33652100 - Antineoplastic agents

Award method
Lowest price
Estimated value
14,766,780.00 CZK
Final contracted value
14,765,323.50 CZK
Award of contract
Official name: Alliance Healthcare s.r.o.
Postal address: Podle trati 624/7
Town: Praha
Postal code: 10800
Country: CZE
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.